Clinical trial
Study Investigating Rapamune For Post-Marketing Surveillance
NCT00484094 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00484094 |
|---|---|
| Title | Study Investigating Rapamune For Post-Marketing Surveillance |
| Official title | Post Marketing Surveillance Study To Observe Safety And Efficacy Of Rapamune |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | sirolimus |
| Enrollment | 209 |
| Start date | Jul 1, 2011 |
| Primary completion | Jun 1, 2015 |
| Completion | Jun 1, 2015 |
| First posted | Jun 8, 2007 |
| Last update posted | Jan 16, 2017 |
| Countries | South Korea |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: